Equity Details
Price & Market Data
Price: $6.70
Daily Change: -$0.32 / 4.78%
Daily Range: $6.41 - $7.12
Market Cap: $507,625,024
Daily Volume: 1,085,574
Performance Metrics
1 Week: 1.22%
1 Month: -2.22%
3 Months: 63.05%
6 Months: 234.3%
1 Year: 568.0%
YTD: 81.37%
About Shattuck Labs, Inc. (STTK)
Understand the current valuation of Shattuck Labs, Inc. (STTK). Trading at 6.70, the stock has observed a daily change of -$0.32 / 4.78%. A robust market capitalization of 507,625,024 underscores its market presence. Key performance indicators include YTD (81.37%) and 1-year (568.0%) returns.
Company Details
Employees: 40
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking monoclonal antibody, which is in Phase I clinical trial for the treatment of tumor necrosis factor like ligand 1A; and SL-425, a half-life extended version of SL-325, which is under IND-enabling chronic good laboratory practices toxicity study. It is also involved in the development of various preclinical DR3-based bispecific antibodies for the treatment of patients with inflammatory bowel disease or other immune-mediated indications; and TRIM7, an oncology-focused program. The company was incorporated in 2016 and is headquartered in Austin, Texas.